243 related articles for article (PubMed ID: 34564901)
1. Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.
Ren Y; Jiang H; Pu J; Li L; Wu J; Yan Y; Zhao G; Guttuso TJ; Zhang B; Feng J
Mov Disord; 2022 Jan; 37(1):70-79. PubMed ID: 34564901
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
Patikas N; Ansari R; Metzakopian E
Neurosci Res; 2023 Oct; 195():13-28. PubMed ID: 37271312
[TBL] [Abstract][Full Text] [Related]
3. Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons.
Corenblum MJ; McRobbie-Johnson A; Carruth E; Bernard K; Luo M; Mandarino LJ; Peterson S; Sans-Fuentes MA; Billheimer D; Maley T; Eggers ED; Madhavan L
Prog Neurobiol; 2023 Oct; 229():102501. PubMed ID: 37451330
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease in a dish - Using stem cells as a molecular tool.
Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
[TBL] [Abstract][Full Text] [Related]
5. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
6. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
[TBL] [Abstract][Full Text] [Related]
8. Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations.
Zhong P; Hu Z; Jiang H; Yan Z; Feng J
Cell Rep; 2017 May; 19(5):1033-1044. PubMed ID: 28467897
[TBL] [Abstract][Full Text] [Related]
9. Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.
Sheta R; Teixeira M; Idi W; Pierre M; de Rus Jacquet A; Emond V; Zorca CE; Vanderperre B; Durcan TM; Fon EA; Calon F; Chahine M; Oueslati A
Sci Rep; 2022 Oct; 12(1):17176. PubMed ID: 36229560
[TBL] [Abstract][Full Text] [Related]
10. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
[TBL] [Abstract][Full Text] [Related]
12. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.
Sison SL; Vermilyea SC; Emborg ME; Ebert AD
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):84. PubMed ID: 30284665
[TBL] [Abstract][Full Text] [Related]
13. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.
Jiang H; Ren Y; Yuen EY; Zhong P; Ghaedi M; Hu Z; Azabdaftari G; Nakaso K; Yan Z; Feng J
Nat Commun; 2012 Feb; 3():668. PubMed ID: 22314364
[TBL] [Abstract][Full Text] [Related]
14. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
Li H; Jiang H; Zhang B; Feng J
J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease.
Cardo LF; Monzón-Sandoval J; Li Z; Webber C; Li M
Cells; 2023 Dec; 12(24):. PubMed ID: 38132179
[TBL] [Abstract][Full Text] [Related]
16. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
[TBL] [Abstract][Full Text] [Related]
17. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
[TBL] [Abstract][Full Text] [Related]
19. Modeling Parkinson's disease using induced pluripotent stem cells.
Byers B; Lee HL; Reijo Pera R
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
[TBL] [Abstract][Full Text] [Related]
20. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
